A Comparison of Three Computational Modelling Methods for the Prediction of Virological Response to Combination Hiv Therapy Author's Personal Copy
暂无分享,去创建一个
Brendan Larder | Dechao Wang | Lidia Ruiz | Andrew Revell | Julio Montaner | Richard Harrigan | Frank De Wolf | Joep Lange | Scott Wegner | María Jésus Pérez-Elías | Sean Emery | Jose Gatell | Antonella D'Arminio Monforte | Carlo Torti | Maurizio Zazzi | H. Clifford Lane | A. d’Arminio Monforte | B. Larder | J. Montaner | L. Ruiz | J. Gatell | M. Zazzi | S. Emery | F. de Wolf | A. Revell | R. Harrigan | C. Torti | Dechao Wang | S. Wegner | J. Lange | M. Pérez-Elías | C. Lane | L. Ruíz | Julio Montaner | Richard Harrigan | Frank de Wolf | Joep Lange | Scott Wegner | Lidia Ruiz | María Jésus Pérez-Elías | Sean Emery | J. Gatell | A. D | Arminio Monforte | C. Torti | Clifford Lane | J. Lange
[1] J. Listgarten,et al. Predictive Models for Breast Cancer Susceptibility from Multiple Single Nucleotide Polymorphisms , 2004, Clinical Cancer Research.
[2] C. Tinelli,et al. Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients. , 2003, The Journal of infectious diseases.
[3] Nello Cristianini,et al. Support vector machine classification and validation of cancer tissue samples using microarray expression data , 2000, Bioinform..
[4] Tom Heskes,et al. Bias/Variance Decompositions for Likelihood-Based Estimators , 1998, Neural Computation.
[5] Brendan Larder,et al. The Development of Artificial Neural Networks to Predict Virological response to Combination HIV Therapy , 2007, Antiviral therapy.
[6] John Shawe-Taylor,et al. Generalization Performance of Support Vector Machines and Other Pattern Classifiers , 1999 .
[7] B. Larder,et al. Enhanced prediction of lopinavir resistance from genotype by use of artificial neural networks. , 2003, The Journal of infectious diseases.
[8] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[9] K. Hertogs,et al. HIV Drug Susceptibility and Treatment Response to Mega-Haart Regimen in Patients from the Frankfurt HIV Cohort , 2000, Antiviral therapy.
[10] Nello Cristianini,et al. Advances in Kernel Methods - Support Vector Learning , 1999 .
[11] Thomas Lengauer,et al. Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Hammer,et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. , 2000, JAMA.
[13] JD Lundgren,et al. Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing , 2004, Antiviral therapy.
[14] R. Samudrala,et al. Simple Linear Model Provides Highly Accurate Genotypic Predictions of HIV-1 Drug Resistance , 2003, Antiviral therapy.
[15] D. Katzenstein,et al. Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects. , 2004, The Journal of infectious diseases.
[16] V. Soriano,et al. Correlation between rules-based interpretation and virtual phenotype interpretation of HIV-1 genotypes for predicting drug resistance in HIV-infected individuals. , 2004, Journal of virological methods.
[17] Thomas Lengauer,et al. Data and text mining Computational methods for the design of effective therapies against drug resistant HIV strains , 2005 .
[18] L. Sandvik,et al. An algorithm‐based genotypic resistance score is associated with clinical outcome in HIV‐1‐infected adults on antiretroviral therapy , 2004, HIV medicine.
[19] Durga L. Shrestha,et al. Machine learning approaches for estimation of prediction interval for the model output , 2006, Neural Networks.
[20] P. Narciso,et al. Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance. , 2003, Journal of Infectious Diseases.
[21] J. J. Henning,et al. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.
[22] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[23] Thomas Lengauer,et al. Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes , 2003, Nucleic Acids Res..
[24] W Preiser,et al. Variety of interpretation systems for human immunodeficiency virus type 1 genotyping: confirmatory information or additional confusion? , 2003, Current drug targets. Infectious disorders.
[25] S. Hammer,et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] Hannu Toivonen,et al. A survey of data mining methods for linkage disequilibrium mapping , 2006, Human Genomics.
[27] S. Staszewski,et al. Comparison of Nine Resistance Interpretation Systems for HIV-1 Genotyping , 2002, Antiviral therapy.
[28] Victor DeGruttola,et al. Clinically Validated Genotype Analysis: Guiding Principles and Statistical Concerns , 2004, Antiviral therapy.